Cancer-associated splicing variant of tumor suppressor AIMP2/p38: Pathological implication in tumorigenesis

PLoS Genetics

Volumn 7, Issue 3, 2011, Pages

  Choi, Jin Woo ^a   Kim, Dae Gyu ^a   Lee, Al Eum ^a   Kim, Hye Rim ^a   Lee, Jin Young ^a   Kwon, Nam Hoon ^a   Shin, Young Kee ^a   Hwang, Soon Kyung ^a   Chang, Seung Hee ^a   Cho, Myung Haing ^a   Choi, Yoon La ^b   Kim, Jhingook ^b   Oh, Seung Hyun ^c   Kim, Bora ^c   Kim, Soo Youl ^c   Jeon, Hyo Sung ^d   Park, Jae Yong ^d   Kang, Hyunseok Peter ^e   Park, Bum Joon ^f   Han, Jung Min ^a   Kim, Sunghoon ^a   more..

^a Seoul National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

^d Kyungpook National University School of Medicine   (South Korea)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARS INTERACTING MULTIFUNCTIONAL PROTEIN 2; BIOLOGICAL MARKER; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; AMINO ACID TRANSFER RNA LIGASE; AMINOACYL TRNA SYNTHETASE ASSOCIATED PROTEIN P38; AMINOACYL-TRNA SYNTHETASE-ASSOCIATED PROTEIN P38;

ADULT; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING COMPETITION; CANCER CELL CULTURE; CANCER INHIBITION; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ADENOCARCINOMA; AGED; ANIMAL; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL; TUMOR CELL LINE;

MUS;

ADENOCARCINOMA; AGED; ALTERNATIVE SPLICING; AMINO ACYL-TRNA SYNTHETASES; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79953766254     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1001351     Document Type: Article

References (41)

1. Stetefeld J, Ruegg MA, (2005) Structural and functional diversity generated by alternative mRNA splicing. Trends Biochem Sci 30: 515-521.
2. Nissim-Rafinia M, Kerem B, (2005) The splicing machinery is a genetic modifier of disease severity. Trends Genet 21: 480-483.
3. Schwerk C, Schulze-Osthoff K, (2005) Regulation of apoptosis by alternative pre-mRNA splicing. Mol Cell 19: 1-13.
4. Park SG, Ewalt KL, Kim S, (2005) Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem Sci 30: 569-574.
5. Lee SW, Cho BH, Park SG, Kim S, (2004) Aminoacyl-tRNA synthetase complexes: beyond translation. J Cell Sci 117: 3725-3734.
6. Han JM, Lee MJ, Park SG, Lee SH, Razin E, et al. (2006) Hierarchical Network between the Components of the Multi-tRNA Synthetase Complex: IMPLICATIONS FOR COMPLEX FORMATION. J Biol Chem 281: 38663-38667.
7. Park SG, Kang YS, Ahn YH, Lee SH, Kim KR, et al. (2002) Dose-dependent biphasic activity of tRNA synthetase-associating factor, p43, in angiogenesis. J Biol Chem 277: 45243-45248.
8. Ko Y-G, Park H, Kim T, Lee J-W, Park SG, et al. (2001) A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes. J Biol Chem 276: 23028-32303.
9. Park H, Park SG, Lee J-W, Kim T, Kim G, Ko Y-G, Kim S, (2002) Monocyte Cell Adhesion Induced by a Human Aminoacyl-tRNA Synthetase Associated Factor, p43: Identification of the Related Adhesion Molecules and Signal Pathways. J Leukoc Biol 71: 223-230.
10. Park SG, Shin H, Shin YK, Lee Y, Choi EC, et al. (2005) The Novel Cytokine p43 Stimulates Dermal Fibroblast Proliferation and Wound Repair. Am J Pathol 166: 387-398.
11. Park SG, Kang YS, Kim JY, Lee CS, Ko YG, et al. (2006) Hormonal activity of AIMP1/p43 for glucose homeostasis. Proc Natl Acad Sci U S A 103: 14913-14918.
12. Han JM, Park SG, Liu B, Park BJ, Kim JY, et al. (2007) Aminoacyl-tRNA Synthetase-Interacting Multifunctional Protein 1/p43 Controls Endoplasmic Reticulum Retention of Heat Shock Protein gp96: Its Pathological Implications in Lupus-Like Autoimmune Diseases. Am J Pathol 170: 2042-2054.
13. Park BJ, Kang JW, Lee SW, Choi SJ, Shin YK, et al. (2005) The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR. Cell 120: 209-221.
14. Kim KJ, Park MC, Choi SJ, Oh YS, Choi EC, et al. (2008) Determination of three dimensional structure and residues of novel tumor suppressor, AIMP3/p18, required for the interaction with ATM. J Biol Chem.
15. Park BJ, Oh YS, Park SY, Choi SJ, Rudolph C, et al. (2006) AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability. Cancer Res 66: 6913-6918.
16. Kim MJ, Park B-J, Kang Y-S, Kim HJ, Park J.-H, Kang JW, Lee SW, Han JM, Lee H-W, Kim S, (2003) Downregulation of fuse-binding protein and c-myc by tRNA synthetase cofactor, p38, is required for lung differentiation. Nature Genetics 34: 330-336.
17. Han JM, Park BJ, Park SG, Oh YS, Choi SJ, et al. (2008) AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53. Proc Natl Acad Sci U S A 105: 11206-11211.
18. Choi JW, Kim DG, Park MC, Um JY, Han JM, et al. (2009) AIMP2/p38 promotes TNF-alpha-dependent apoptosis via ubiquitin-mediated degradation of TRAF2. J Cell Sci 122: 2710-2715.
19. Choi JW, Um JY, Kundu JK, Surh YJ, Kim S, (2009) Multidirectional tumor-suppressive activity of AIMP2/p38 and the enhanced susceptibility of AIMP2 heterozygous mice to carcinogenesis. Carcinogenesis 30: 1638-1644.
20. Kwon MJ, Oh E, Lee S, Roh MR, Kim SE, et al. (2009) Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis. PLoS ONE 4: e6162 doi:10.1371/journal.pone.0006162.
21. Bonano VI, Oltean S, Garcia-Blanco MA, (2007) A protocol for imaging alternative splicing regulation in vivo using fluorescence reporters in transgenic mice. Nat Protoc 2: 2166-2181.
22. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR, (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31: 3568-3571.
23. Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, et al. (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15: 2490-2508.
24. Karni R, de Stanchina E, Lowe SW, Sinha R, Mu D, et al. (2007) The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 14: 185-193.
25. Karni R, Hippo Y, Lowe SW, Krainer AR, (2008) The splicing-factor oncoprotein SF2/ASF activates mTORC1. Proc Natl Acad Sci U S A 105: 15323-15327.
26. Pio R, Montuenga LM, (2009) Alternative splicing in lung cancer. J Thorac Oncol 4: 674-678.
27. Quevillon S, Robinson J-C, Berthonneau E, Siatecka M, Mirande M, (1999) Macromolecular assemblage of aminoacyl-tRNA synthetases: Identification of protein-protein interactions and characterization of a core protein. J Mol Biol 285: 183-195.
28. Park SG, Jung KH, Lee JS, Jo YJ, Motegi H, et al. (1999) Precursor of pro-apoptotic cytokine modulates aminoacylation activity of tRNA synthetase. J Biol Chem 274: 16673-16676.
29. Li HR, Wang-Rodriguez J, Nair TM, Yeakley JM, Kwon YS, et al. (2006) Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens. Cancer Res 66: 4079-4088.
30. Nanjundan M, Zhang F, Schmandt R, Smith-McCune K, Mills GB, (2007) Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions. Oncogene 26: 2574-2584.
31. Tacconelli A, Farina AR, Cappabianca L, Desantis G, Tessitore A, et al. (2004) TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 6: 347-360.
32. Ghosh A, Stewart D, Matlashewski G, (2004) Regulation of human p53 activity and cell localization by alternative splicing. Mol Cell Biol 24: 7987-7997.
33. Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, et al. (2005) p53 isoforms can regulate p53 transcriptional activity. Genes Dev 19: 2122-2137.
34. Park BJ, Lee SJ, Kim JI, Lee CH, Chang SG, et al. (2000) Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 60: 3370-3374.
35. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718.
36. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, et al. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713.
37. Park SG, Schimmel P, Kim S, (2008) Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci U S A 105: 11043-11049.
38. Park SG, Choi EC, Kim S, (2010) Aminoacyl-tRNA synthetase-interacting multifunctional proteins (AIMPs): a triad for cellular homeostasis. IUBMB Life 62: 296-302.
39. Arote RB, Hwang SK, Yoo MK, Jere D, Jiang HL, et al. (2008) Biodegradable poly(ester amine) based on glycerol dimethacrylate and polyethylenimine as a gene carrier. J Gene Med 10: 1223-1235.
40. Kim HW, Park IK, Cho CS, Lee KH, Beck GR Jr, et al. (2004) Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res 64: 7971-7976.
41. Kwon TK, Nordin AA, (1998) Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor. Oncogene 16: 755-762.